BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 115706
Published online Jun 27, 2026. doi: 10.4240/wjgs.115706
Table 1 Baseline characteristics in no clinically relevant postoperative pancreatic fistula and clinically relevant postoperative pancreatic fistula groups following laparoscopic pancreaticoduodenectomy, mean ± SD/median (interquartile range)
Parameter
No CR-POPF (n = 36)
CR-POPF (n = 31)
P value
Gender0.142
Male1922
Female179
Age (years)66 (58, 70.75)64 (56, 74)0.988
Body mass index (kg/cm2)19.78 ± 3.2518.65 ± 3.040.165
Pathological type0.333
Pancreatic cancer156
Bile duct cancer911
Ampullary cancer65
Duodenal malignancy45
Other24
Operation time (minutes)360 (322.5, 415)348 (300, 460)0.933
Intraoperative bleeding (mL)145 (100, 500)170 (145, 280)0.42
Intraoperative transfusion0.089
Yes1217
No2414
Hospital stays (days)24 (20, 30.25)35 (27, 42)0.001
Drain fluid amylase concentration (U/L)
POD12304 (1195, 3496)7177 (4386, 11581)< 0.001
POD3415.5 (222.3, 3311)1860 (1370, 2888)0.037
Serum amylase concentration (U/L)
POD181.83 (23.4, 199.9)156 (89.65, 307.8)0.049
POD339.05 (25.29, 360.4)53.21 (17.42, 86.53)0.522
Drain-to-serum amylase concentration ratio
POD122.05 (10.4, 48.65)37 (23, 48)0.022
POD39.55 (5.625, 13.18)42 (25, 80)< 0.001
Table 2 Diagnostic accuracy of biomarkers for clinically relevant postoperative pancreatic fistula following laparoscopic pancreaticoduodenectomy on postoperative day 1
ROC curve analysis
Drain fluid amylase concentration (U/L)
Serum amylase concentration (U/L)
Drain-to-serum amylase concentration ratio
C-reactive protein (pg/mL)
IL-8 (pg/mL)
IL-6 (pg/mL)
Areas under the ROC curve0.8660.6410.6620.6580.7080.812
95%CI0.760-0.9370.514-0.7540.536-0.7730.532-0.7690.584-0.8130.698-0.897
P value< 0.0010.0410.0170.0190.003< 0.001
Youden index J0.6720.3020.34860.3080.5430.534
Associated criterion> 3767> 82.68> 24.9> 135.1> 88.09> 244.91
Sensitivity83.8777.4270.9741.9470.9764.52
Specificity83.3352.7863.8988.8983.3388.89
Table 3 Diagnostic accuracy of biomarkers for clinically relevant postoperative pancreatic fistula following laparoscopic pancreaticoduodenectomy on postoperative day 3
ROC curve analysis
Serum amylase concentration (U/L)
Drain fluid amylase concentration (U/L)
Drain-to-serum amylase concentration ratio
C-reactive protein (pg/mL)
IL-8 (pg/mL)
IL-6 (pg/mL)
Areas under the ROC curve0.6480.5460.8650.7900.8750.893
95%CI0.522-0.7610.420-0.6680.760-0.9360.674-0.8800.772-0.9430.794-0.956
P value0.0430.525< 0.001< 0.001< 0.001< 0.001
Youden index J0.54660.26880.80110.5150.6350.668
Associated criterion> 734≤ 168.36> 14> 336.19> 78.23> 177.9
Sensitivity93.5593.5596.7770.9777.4280.65
Specificity61.1133.3383.3380.5686.1186.11
Table 4 Pairwise receiver operating characteristic curve comparison of biomarkers for clinically relevant postoperative pancreatic fistula detection
Pairwise comparison of receiver operating characteristic curves
POD1
POD3
CRP vs DACDifference between areas0.2080.142
P value0.0170.118
CRP vs DSACRDifference between areas0.0040.075
P value0.9610.342
CRP vs IL-6Difference between areas0.1540.103
P value0.0860.100
CRP vs IL-8Difference between areas0.0500.085
P value0.6270.173
CRP vs SACDifference between areas0.0170.244
P value0.8640.008
DAC vs DSACRDifference between areas0.2030.217
P value0.0070.009
DAC vs IL-6Difference between areas0.0540.245
P value0.4410.005
DAC vs IL-8Difference between areas0.1580.227
P value0.0790.006
DAC vs SACDifference between areas0.2250.102
P value0.0010.443
DSACR vs IL-6Difference between areas0.1500.028
P value0.1230.671
DSACR vs IL-8Difference between areas0.0460.010
P value0.6620.881
DSACR vs SACDifference between areas0.0220.319
P value0.8625< 0.001
IL-6 vs IL-8Difference between areas0.1040.018
P value0.2390.744
IL-6 vs SACDifference between areas0.1710.347
P value0.025< 0.001
IL-8 vs SACDifference between areas0.0670.329
P value0.477< 0.001


Write to the Help Desk